RBC Analyst Questions Chemring’s Ability to Meet FY2026 Guidance
RBC Capital Markets’ Ben Pfannes-Varrow says Chemring may struggle to meet fiscal 2026 guidance despite a deal worth at least $170 million over its first five years. The company has about two weeks left in its financial year.
Story updates
08:57:25 AM UTC
SquawkNews
Chemring's strategic agreement should remind investors of its underappreciated revenue streams that rarely feature in investment discussions, Jefferies analysts say in a note. The new deal--worth at least $170 million over the first five years--replaces the January 2025 award that saw $32 million o…